Evidence map›Paper›PMID 30928446›Full record

Observational studyJACC. Cardiovascular interventions2019

Timing and Causes of Unplanned Readmissions After Percutaneous Coronary Intervention: Insights From the Nationwide Readmission Database.

Chun Shing Kwok, Binita Shah, Jassim Al-Suwaidi, David L Fischman, Lene Holmvang, Chadi Alraies, Rodrigo Bagur, Vinayak Nagaraja, Muhammad Rashid, Mohamed Mohamed and 4 more

Abstract readObservational Study
In one paragraph

Observational study in JACC. Cardiovascular interventions, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Study on the management effect of chronic disease intelligent information management platform in post percutaneous coronary intervention patients.Technology and health care : official journal of the European Society for Engineering and Medicine · 2024
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Chun Shing KwokKeele Cardiovascular Research Group, Keele University, Stoke-on-Trent, United Kingdom; Royal Stoke University Hospital, Stoke-on-Trent, United Kingdom.
Binita ShahVA New York Harbor Healthcare System, New York University School of Medicine, New York, New York.
Jassim Al-SuwaidiHeart Hospital, Hamad Medical Corporation and Weill Cornell Medical College, Doha, Qatar.
David L FischmanThomas Jefferson University Hospital, Philadelphia, Pennsylvania.
Lene HolmvangDepartment of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Chadi AlraiesWayne State University School of Medicine, Detroit Heart Hospital, Detroit, Michigan.
Rodrigo BagurKeele Cardiovascular Research Group, Keele University, Stoke-on-Trent, United Kingdom.
Vinayak NagarajaKeele Cardiovascular Research Group, Keele University, Stoke-on-Trent, United Kingdom; Royal Stoke University Hospital, Stoke-on-Trent, United Kingdom.
Muhammad RashidKeele Cardiovascular Research Group, Keele University, Stoke-on-Trent, United Kingdom.
Mohamed MohamedKeele Cardiovascular Research Group, Keele University, Stoke-on-Trent, United Kingdom; Royal Stoke University Hospital, Stoke-on-Trent, United Kingdom.
Glen P MartinDivision of Informatics, Imaging and Data Science, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom.
Evan KontopantelisDivision of Informatics, Imaging and Data Science, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom.
Tim KinnairdDepartment of Cardiology, University Hospital of Wales, Cardiff, United Kingdom.
Mamas MamasKeele Cardiovascular Research Group, Keele University, Stoke-on-Trent, United Kingdom; Royal Stoke University Hospital, Stoke-on-Trent, United Kingdom. Electronic address: mamasmamas1@yahoo.co.uk.

Funding

Anti-inflammatory therapy during percutaneous coronary interventionIK2CX001074 · VA · VA MEDICAL CENTER · PI SHAH, BINITA · 2016 to 2021
–
CSRD VA IK2 CX001074
6 · The paper itself

Abstract

objectivesThe aim of this study was to describe the rates and causes of unplanned readmissions at different time periods following percutaneous coronary intervention (PCI).

backgroundThe rates and causes of readmission at different time periods after PCI remain incompletely elucidated.

methodsPatients undergoing PCI between 2010 and 2014 in the U.S. Nationwide Readmission Database were evaluated for the rates, causes, predictors, and costs of unplanned readmission between 0 and 7 days, 8 and 30 days, 31 and 90 days, and 91 and 180 days after index discharge.

resultsThis analysis included 2,412,000 patients; 2.5% were readmitted between 0 and 7 days, 7.6% between 8 and 30 days, 8.9% between 31 and 90 days, and 8.0% between 91 and 180 days (cumulative rates 2.5%, 9.9%, 18.0%, and 24.8%, respectively). The majority of readmissions during each time period were due to noncardiac causes (53.1% to 59.6%). Nonspecific chest pain was the most common identifiable noncardiac cause for readmission during each time period (14.2% to 22.7% of noncardiac readmissions). Coronary artery disease including angina was the most common cardiac cause for readmission during each time period (37.4% to 39.3% of cardiac readmissions). The second most common cardiac cause for readmission was acute myocardial infarction between 0 and 7 days (27.6% of cardiac readmissions) and heart failure during all subsequent time periods (22.2% to 23.7% of cardiac readmissions).

conclusionsApproximately 25% of patients following PCI have unplanned readmissions within 6 months. Causes of readmission depend on the timing at which they are assessed, with noncardiovascular causes becoming more important at longer time points.

Indexed as

AgedAged, 80 and overDatabases, FactualFemaleHospital CostsHumansMaleMiddle AgedPatient DischargePatient ReadmissionPercutaneous Coronary InterventionRetrospective StudiesRisk FactorsTime FactorsTreatment OutcomeUnited Statescostpercutaneous coronary interventionreadmissions

Identifiers

PMID30928446
PMCPMC6843988

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.